| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 04/12/2007 | WO2007039145A1 C (2) -heteroarylmethyl-c (4) -pyrazinyl-2-yl acyl pyrrolidine compounds and their use for treating viral infections, especially hepatitis c virus |
| 04/12/2007 | WO2007039144A1 Pyrrolidine derivatives for treating viral infections |
| 04/12/2007 | WO2007039143A1 C (2) -heteroarylmethyl-c (4) -pyrazin-2-yl acyl pyrrolidine compounds and their user for treating viral infections, especially hepatitics c (hcv) |
| 04/12/2007 | WO2007039142A1 C (2) -heteroarylmethyl-c (4) -methoxymethyl acyl pyrrolidine compounds and their use for treating viral infections, especially hepatitis c virus |
| 04/12/2007 | WO2007038876A1 Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity |
| 04/12/2007 | WO2007038875A1 Ccr5 receptor antagonist molecules |
| 04/12/2007 | WO2007038869A1 Aptamers comprising arabinose modified nucleotides |
| 04/12/2007 | WO2007038862A1 Nucleic acid immunological composition for human metapneumovirus |
| 04/12/2007 | WO2007038855A1 Medical gel |
| 04/12/2007 | WO2007016292A3 Heterocyclic amides as biofilm modulators |
| 04/12/2007 | WO2007015812A3 Hiv reverse transcriptase inhibitors |
| 04/12/2007 | WO2007009055A3 Ester prodrugs of prostratin and related phorbol compounds |
| 04/12/2007 | WO2006138230A3 The preparation and use of protease inhibitors |
| 04/12/2007 | WO2006128026A3 Cellular receptor for varicella-zoster virus, methods of inhibiting spread of varicella-zoster and methods of increasing stability and infectivity of the virus |
| 04/12/2007 | WO2006127822A3 Scytovirin domain 1 related polypeptides |
| 04/12/2007 | WO2006120563A3 Antibacterial agents |
| 04/12/2007 | WO2006071564A3 Aminium salts of 1,2,3-triazoles as prodrugs of drugs including antiviral agents |
| 04/12/2007 | US20070083045 Dihydroxypyrimidine carboxamide inhibitors of HIV integrase |
| 04/12/2007 | US20070082942 Prevention of hiv-1 infection by inhibition of rho-mediated reorganization and/or content alteration of cell membrane raft |
| 04/12/2007 | US20070082911 Novel use of quinolone antibiotics |
| 04/12/2007 | US20070082883 HIV protease inhibitors |
| 04/12/2007 | US20070082862 Novel antisense oligonucleotide and anti-hiv agent |
| 04/12/2007 | US20070082382 Development of human monoclonal antibodies and uses thereof |
| 04/12/2007 | US20070082375 Topically administering to a nail of subject having onychomycosis a therapeutically effective amount of an antifungal compound such as (2R, 3R)-2-(2,4-difluorophenyl)-3-(4-methylen piperidine-1-yl)-1-(1H-1,2,4-triazole-1-yl)butane-2-ol |
| 04/12/2007 | US20070082361 DNA and proteins or peptides specific of bacteria of the Neisseria meningitidis species, methods for obtaining them and biological applications thereof |
| 04/12/2007 | US20070082341 Human phospholipases |
| 04/12/2007 | US20070082068 Il-8 production promoters and use thereof |
| 04/12/2007 | US20070082041 Topical delivery of codrugs |
| 04/12/2007 | US20070082010 Urogenital or anorectal transmucosal vaccine delivery system |
| 04/12/2007 | US20070082002 Neutralizing High Affinity Human Monoclonal Antibodies Specific to RSV F-Protein and Methods for their Manufacture and Therapeutic use thereof |
| 04/12/2007 | CA2625183A1 Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity |
| 04/12/2007 | CA2625074A1 Use of lactobacillus for treatment of virus infections |
| 04/12/2007 | CA2624501A1 Antibacterial pyrrols |
| 04/12/2007 | CA2624291A1 Nucleic acid immunological composition for human metapneumovirus |
| 04/12/2007 | CA2624141A1 Quinazoline derivative and pharmaceutical |
| 04/12/2007 | CA2623865A1 Methods and pharmaceutical compositions for the treatment and prevention of hepatitis c infection |
| 04/12/2007 | CA2623864A1 Arylalkyl and heteroarylalkyl derivatives of cyclosporine a for the treatment and prevention of viral infection |
| 04/12/2007 | CA2623822A1 1h-benzimidazole-4-carboxamides substituted with phenyl at the 2-position are potent parp inhibitors |
| 04/12/2007 | CA2623818A1 Aptamers comprising arabinose modified nucleotides |
| 04/12/2007 | CA2623735A1 Method for production of t cell population |
| 04/12/2007 | CA2623728A1 Nnrt inhibitors |
| 04/12/2007 | CA2623534A1 Inhibitors of the hiv integrase enzyme |
| 04/12/2007 | CA2609953A1 Saccharide foamable compositions |
| 04/11/2007 | EP1772518A2 Mammalian-type glycosylation in plants |
| 04/11/2007 | EP1772464A2 Methods of identifying indirect agonists of IGF-1 |
| 04/11/2007 | EP1772457A2 Preparation of levofloxacin and forms thereof |
| 04/11/2007 | EP1772155A1 Medicament for treating avian influenza |
| 04/11/2007 | EP1772151A2 Method and compositions for the synthesis of bch-189 and related compounds |
| 04/11/2007 | EP1771571A2 Recombinant aav based vaccine methods |
| 04/11/2007 | EP1771456A2 Hybrid qa molecules wherein q is an aminoquinoline and a is an antibiotic residue, their synthesis and their uses as antibacterial agent |
| 04/11/2007 | EP1771454A1 Hepatitis c inhibitor peptide analogs |
| 04/11/2007 | EP1771453A1 Hepatitis c inhibitor dipeptide analogs |
| 04/11/2007 | EP1771452A2 Inhibitors of 5'-methylthioadenosine phosphorylase and 5'methylthioadenosine/s-adenosylhomocysteine nucleosidase |
| 04/11/2007 | EP1771442A1 Viral polymerase inhibitors |
| 04/11/2007 | EP1771425A1 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof |
| 04/11/2007 | EP1771186A1 Herbal composition |
| 04/11/2007 | EP1771181A2 Phosphole derivatives complexed with metals, and pharmaceutical uses thereof |
| 04/11/2007 | EP1771178A1 Use of k-252a and kinase inhibitors for the prevention or treatment of hmgb1-associated pathologies |
| 04/11/2007 | EP1771175A1 Phthalazine derivatives as parp inhibitors |
| 04/11/2007 | EP1771172A2 Treatment of tumours |
| 04/11/2007 | EP1771169A1 Methods for treating hepatitis c |
| 04/11/2007 | EP1715879B1 Onion extracts |
| 04/11/2007 | EP1511759A4 Modulators and inhibitors of fibroblast growth factor receptor 5-polypeptides and gene expression thereof. |
| 04/11/2007 | EP1435985B1 Medicament containing activated antithrombin iii |
| 04/11/2007 | EP1399444B1 Novel heterocyclic compounds, method for preparing same and use thereof as medicines, in particular as anti-bacterial agents |
| 04/11/2007 | EP1383563A4 Methods for the treatment of hiv and other viruses |
| 04/11/2007 | EP1341767B1 Imidazole and benzimidazole caspase inhibitors and uses thereof |
| 04/11/2007 | EP1313471B1 Benzylidene thiazolidinediones and their use as antimycotic agents |
| 04/11/2007 | EP1054683B1 Modified heat shock protein-antigenic peptide complex |
| 04/11/2007 | EP0988379B1 Ldl-receptor |
| 04/11/2007 | CN2887309Y Microcapsule of timulin fumarate |
| 04/11/2007 | CN1946720A Azabenzofuran substituted thioureas; inhibitors of viral replication |
| 04/11/2007 | CN1946718A Novel ketoamides with cyclic P4's as inhibitors of NS3 serine protease of hepatitis C virus |
| 04/11/2007 | CN1946692A 3,4-(cyclopentyl)-fused proline compounds as inhibitors of hepatitis C virus NS3 serine protease |
| 04/11/2007 | CN1946680A 非核苷逆转录酶抑制剂 Non-nucleoside reverse transcriptase inhibitors |
| 04/11/2007 | CN1946679A Amino-propanol derivatives |
| 04/11/2007 | CN1946424A Treatment of fungal infections |
| 04/11/2007 | CN1946410A Anti-viral pharmaceutical compositions |
| 04/11/2007 | CN1946395A 1H-thieno[2,3-c]pyrazole derivatives useful as kinase inhibitors |
| 04/11/2007 | CN1946385A Use of targeted oxidative therapeutic formulation in treatment of viral diseases |
| 04/11/2007 | CN1944652A Group B streptococcus antigens |
| 04/11/2007 | CN1944644A Process for preparing HIV-lgp120 and human gamma-interferon fusion protein |
| 04/11/2007 | CN1944462A Preparation of anti PV IgY antibody and its use in PV diagnostic reagent and preventing medicine |
| 04/11/2007 | CN1944458A Protein and small molecule polypeptide for increasing lysozyme bacteriolysis activity and its use |
| 04/11/2007 | CN1944452A 2-phenoxy chromone heteroside compounds and its preparing method and use |
| 04/11/2007 | CN1943789A The DNA vaccine of an anti-infection of hepatitis C virus |
| 04/11/2007 | CN1943788A The E type DNA vaccine of Chlamydi trachomatis and its preparation methods and applications |
| 04/11/2007 | CN1943784A New vaccine adjuvant |
| 04/11/2007 | CN1943782A Medicament for treating avian influenza |
| 04/11/2007 | CN1943781A Orally administered peptides to ameliorate atherosclerosis |
| 04/11/2007 | CN1943779A The processing method of bupleurum root preparation and its application |
| 04/11/2007 | CN1943770A A Chinese traditional medicine for treatment of hepatitis and its preparation methods |
| 04/11/2007 | CN1943764A The Chinese herbal medicinal pills for treatment of hepatitis B and liver cancer |
| 04/11/2007 | CN1943753A A Chinese traditional medicinal composition for treatment of hepatitis B and its preparation method |
| 04/11/2007 | CN1943748A Cold treating medicine |
| 04/11/2007 | CN1943742A A medicine for treatment of AIDS |
| 04/11/2007 | CN1943729A A Chinese traditional medicinal composition for treatment of exopathic febrile disease and its preparation method |
| 04/11/2007 | CN1943728A A first-aid medicine for treatment of tetanus and lyssodexis |
| 04/11/2007 | CN1943718A A Chinese traditional medicinal composition and its preparation method |
| 04/11/2007 | CN1943697A Dermatophytosis liquid |